Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24003225)

  • 1. Prohibitin-2 binding modulates insulin-like growth factor-binding protein-6 (IGFBP-6)-induced rhabdomyosarcoma cell migration.
    Fu P; Yang Z; Bach LA
    J Biol Chem; 2013 Oct; 288(41):29890-900. PubMed ID: 24003225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.
    Fu P; Liang GJ; Khot SS; Phan R; Bach LA
    J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6.
    Fu P; Thompson JA; Bach LA
    J Biol Chem; 2007 Aug; 282(31):22298-306. PubMed ID: 17519236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current ideas on the biology of IGFBP-6: More than an IGF-II inhibitor?
    Bach LA
    Growth Horm IGF Res; 2016; 30-31():81-86. PubMed ID: 27681092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell Lines.
    Yang Z; Bach LA
    Front Endocrinol (Lausanne); 2014; 5():231. PubMed ID: 25601855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action.
    Srinivasan N; Edwall D; Linkhart TA; Baylink DJ; Mohan S
    J Endocrinol; 1996 May; 149(2):297-303. PubMed ID: 8708541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis.
    Zhang C; Lu L; Li Y; Wang X; Zhou J; Liu Y; Fu P; Gallicchio MA; Bach LA; Duan C
    Int J Cancer; 2012 May; 130(9):2003-12. PubMed ID: 21618524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells.
    Zhou Z; Ai H; Li K; Yao X; Zhu W; Liu L; Yu C; Song Z; Bao Y; Huang Y; Wu Y; Zheng L; Sun Y; Wang G; Ma K; Sun L; Li Y
    Sci Rep; 2018 Jan; 8(1):1479. PubMed ID: 29367618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification from transformed mouse fibroblast of a cell growth inhibitor which is an IGF-binding protein.
    Blat C; Villaudy J; Delbé J; Troalen F; Golde A; Harel L
    Growth Factors; 1992; 6(1):65-75. PubMed ID: 1375478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import.
    Iosef C; Gkourasas T; Jia CY; Li SS; Han VK
    Endocrinology; 2008 Mar; 149(3):1214-26. PubMed ID: 18039785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding.
    Headey SJ; Leeding KS; Norton RS; Bach LA
    J Mol Endocrinol; 2004 Oct; 33(2):377-86. PubMed ID: 15525596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis.
    Marinaro JA; Neumann GM; Russo VC; Leeding KS; Bach LA
    Eur J Biochem; 2000 Sep; 267(17):5378-86. PubMed ID: 10951195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins.
    Hsieh T; Gordon RE; Clemmons DR; Busby WH; Duan C
    J Biol Chem; 2003 Oct; 278(44):42886-92. PubMed ID: 12917428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of ligand occupancy in Insulin-like growth factor-I (IGF-I) induced cell growth in osteoblast like MC3T3-E1 cells.
    Kim SK; Kwon JY; Nam TJ
    Biofactors; 2007; 29(4):187-202. PubMed ID: 18057550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an insulin-like growth factor binding protein fusion protein on thymidine incorporation in neuroblastoma and rhabdomyosarcoma cell lines.
    Dake BL; Boes M; Bach LA; Bar RS
    Endocrinology; 2004 Jul; 145(7):3369-74. PubMed ID: 15090464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of IGF binding protein synthesis by a bovine mammary epithelial cell line.
    Cohick WS; Turner JD
    J Endocrinol; 1998 May; 157(2):327-36. PubMed ID: 9659296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-6: the "forgotten" binding protein?
    Bach LA
    Horm Metab Res; 1999; 31(2-3):226-34. PubMed ID: 10226806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
    Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
    J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells.
    Andress DL
    J Biol Chem; 1995 Nov; 270(47):28289-96. PubMed ID: 7499327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.